+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
FEMALE
ID07166094

Comparing Rina-S With Physicians Choice Chemotherapy for Women With Recurrent or Progressive Endometrial Cancer After Prior Platinum and PDL-1 Therapy

Led by Genmab · Updated on 2026-11-03

660

Participants Needed

178

Research Sites

13 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating how well Rina-S GEN1184 works compared to standard chemotherapy treatments chosen by a physician for women with recurrent or progressive endometrial cancer who have had prior therapy. This randomized, open-label Phase 3 study involves about 660 participants and aims to assess progression-free survival and overall survival over approximately three years. The study is sponsored by Genmab and focuses on treatment after platinum-based chemotherapy and PDL-1 therapy. Participants are randomly assigned to one of two groups one group receives Rina-S intravenously every three weeks, and the other receives one of two chemotherapy drugspaclitaxel on days 1, 8, and 15 every four weeks, or doxorubicin on day 1 every three weekschosen by the investigator before randomization. Treatment duration varies but typically lasts between 4 to 6 months. No participants receive placebo all receive an active drug. Throughout the study, participants will visit study sites regularly for treatment and monitoring. Researchers will conduct evaluations including imaging scans to assess tumor response, monitor health status and quality of life, and track any treatment-related side effects. These assessments will continue for up to about three years to measure outcomes like progression-free survival and overall survival, ensuring close safety monitoring and comprehensive data collection during the participation period.

CONDITIONS

Brief Title

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

Research Team

G

Genmab Trial Information

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here